Prakash Doddapattar1, Chintan Gandhi1, Prem Prakash1, Nirav Dhanesha1, Isabella M Grumbach1, Michael E Dailey1, Steven R Lentz1, Anil K Chauhan2. 1. From the Department of Internal Medicine (P.D., C.G., P.P., N.D., I.M.G., S.R.L., A.K.C.), and Department of Biology (M.E.D.), University of Iowa, Iowa City. 2. From the Department of Internal Medicine (P.D., C.G., P.P., N.D., I.M.G., S.R.L., A.K.C.), and Department of Biology (M.E.D.), University of Iowa, Iowa City. anil-chauhan@uiowa.edu.
Abstract
OBJECTIVE: Cellular fibronectin containing extra domain A (EDA(+)-FN) is abundant in the arteries of patients with atherosclerosis. Several in vitro studies suggest that EDA(+)-FN interacts with Toll-like receptor 4 (TLR4). We tested the hypothesis that EDA(+)-FN exacerbates atherosclerosis through TLR4 in a clinically relevant model of atherosclerosis, the apolipoprotein E-deficient (Apoe(-/-)) mouse. APPROACH AND RESULTS: The extent of atherosclerosis was evaluated in whole aortae and cross sections of the aortic sinus in male and female EDA(-/-)Apoe(-/-) mice (which lack EDA(+)-FN), EDA(fl/fl)Apoe(-/-) mice (which constitutively express EDA(+)-FN), and control Apoe(-/-) mice fed a high-fat Western diet for 14 weeks. Irrespective of sex, EDA(fl/fl)Apoe(-/-) mice exhibited a 2-fold increase in atherosclerotic lesions (aorta and aortic sinus) and macrophage content within plaques, whereas EDA(-/-)Apoe(-/-) mice exhibited reduced atherosclerotic lesions (P<0.05 versus Apoe(-/-), n=10-12 mice/group), although cholesterol and triglyceride levels and circulating leukocytes were similar. Genetic ablation of TLR4 partially reversed atherosclerosis exacerbation in EDA(fl/fl)Apoe(-/-) mice (P<0.05) but had no effect on atherosclerotic lesions in EDA(-/-)Apoe(-/-) mice. Purified cellular FN, which contains EDA, potentiated dose-dependent NFκB-mediated inflammation (increased phospho-NFκB p65/NFκB p65, tumor necrosis factor-α, and interleukin-1β) in bone marrow-derived macrophages from EDA(-/-)Apoe(-/-) mice but not from EDA(-/-)TLR4(-/-)Apoe(-/-) mice. Finally, using immunohistochemistry, we provide evidence for the first time that EDA(+)-FN colocalizes with macrophage TLR4 in murine aortic lesions and human coronary artery atherosclerotic plaques. CONCLUSIONS: Our findings reveal that TLR4 signaling contributes to EDA(+)-FN-mediated exacerbation of atherosclerosis. We suggest that EDA(+)-FN could be a therapeutic target in atherosclerosis.
OBJECTIVE: Cellular fibronectin containing extra domain A (EDA(+)-FN) is abundant in the arteries of patients with atherosclerosis. Several in vitro studies suggest that EDA(+)-FN interacts with Toll-like receptor 4 (TLR4). We tested the hypothesis that EDA(+)-FN exacerbates atherosclerosis through TLR4 in a clinically relevant model of atherosclerosis, the apolipoproteinE-deficient (Apoe(-/-)) mouse. APPROACH AND RESULTS: The extent of atherosclerosis was evaluated in whole aortae and cross sections of the aortic sinus in male and female EDA(-/-)Apoe(-/-) mice (which lack EDA(+)-FN), EDA(fl/fl)Apoe(-/-) mice (which constitutively express EDA(+)-FN), and control Apoe(-/-) mice fed a high-fat Western diet for 14 weeks. Irrespective of sex, EDA(fl/fl)Apoe(-/-) mice exhibited a 2-fold increase in atherosclerotic lesions (aorta and aortic sinus) and macrophage content within plaques, whereas EDA(-/-)Apoe(-/-) mice exhibited reduced atherosclerotic lesions (P<0.05 versus Apoe(-/-), n=10-12 mice/group), although cholesterol and triglyceride levels and circulating leukocytes were similar. Genetic ablation of TLR4 partially reversed atherosclerosis exacerbation in EDA(fl/fl)Apoe(-/-) mice (P<0.05) but had no effect on atherosclerotic lesions in EDA(-/-)Apoe(-/-) mice. Purified cellular FN, which contains EDA, potentiated dose-dependent NFκB-mediated inflammation (increased phospho-NFκB p65/NFκB p65, tumor necrosis factor-α, and interleukin-1β) in bone marrow-derived macrophages from EDA(-/-)Apoe(-/-) mice but not from EDA(-/-)TLR4(-/-)Apoe(-/-) mice. Finally, using immunohistochemistry, we provide evidence for the first time that EDA(+)-FN colocalizes with macrophage TLR4 in murineaortic lesions and humancoronary artery atherosclerotic plaques. CONCLUSIONS: Our findings reveal that TLR4 signaling contributes to EDA(+)-FN-mediated exacerbation of atherosclerosis. We suggest that EDA(+)-FN could be a therapeutic target in atherosclerosis.
Authors: Yung-Feng Liao; Philip J Gotwals; Victor E Koteliansky; Dean Sheppard; Livingston Van De Water Journal: J Biol Chem Date: 2002-02-11 Impact factor: 5.157
Authors: Kathrin S Michelsen; Michelle H Wong; Prediman K Shah; Wenxuan Zhang; Juliana Yano; Terence M Doherty; Shizuo Akira; Tripathi B Rajavashisth; Moshe Arditi Journal: Proc Natl Acad Sci U S A Date: 2004-07-12 Impact factor: 11.205
Authors: Michelle H Tan; Zhengwu Sun; Sarah L Opitz; Tracy E Schmidt; John H Peters; Elizabeth L George Journal: Blood Date: 2004-02-19 Impact factor: 22.113
Authors: Andres F Muro; Anil K Chauhan; Srecko Gajovic; Alessandra Iaconcig; Fabiola Porro; Giorgio Stanta; Francisco E Baralle Journal: J Cell Biol Date: 2003-07-07 Impact factor: 10.539
Authors: M A Glukhova; M G Frid; B V Shekhonin; T D Vasilevskaya; J Grunwald; M Saginati; V E Koteliansky Journal: J Cell Biol Date: 1989-07 Impact factor: 10.539
Authors: Manish Jain; Nirav Dhanesha; Prakash Doddapattar; Mehul R Chorawala; Manasa K Nayak; Anne Cornelissen; Liang Guo; Aloke V Finn; Steven R Lentz; Anil K Chauhan Journal: J Clin Invest Date: 2020-01-02 Impact factor: 14.808
Authors: Zaki Al-Yafeai; Arif Yurdagul; Jonette M Peretik; Mabruka Alfaidi; Patrick A Murphy; A Wayne Orr Journal: Arterioscler Thromb Vasc Biol Date: 2018-11 Impact factor: 8.311
Authors: Nirav Dhanesha; Manish Jain; Amit K Tripathi; Prakash Doddapattar; Mehul Chorawala; Girish Bathla; Manasa K Nayak; Madankumar Ghatge; Steven R Lentz; Shigeyuki Kon; Anil K Chauhan Journal: Circ Res Date: 2020-03-20 Impact factor: 17.367